Please login to the form below

Not currently logged in
Email:
Password:

Radicava

This page shows the latest Radicava news and features for those working in and with pharma, biotech and healthcare.

Mitsubishi buys Israel's NeuroDerm for $1.1bn

Mitsubishi buys Israel's NeuroDerm for $1.1bn

The Parkinson's disease candidates will extend Mitsubishi's CNS portfolio in the US, which will see a major launch next month when the Japanese company introduces Radicava (edaravone), a new

Latest news

  • FDA clears new ALS drug Radicava ahead of schedule FDA clears new ALS drug Radicava ahead of schedule

    FDA clears new ALS drug Radicava ahead of schedule. MT Pharma’s medicine will soon offer US patients an alternative to Sanofi’s Rilutek. ... Patients with the chronic neurodegenerative disease amyotrophic lateral sclerosis (ALS) have a new treatment

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics